SCML4: Sex Comb on Midleg-Like Protein 4 (Isoform A) (G256380)

Target Name: SCML4

NCBI ID: G256380

SCML4

SCML4: Sex Comb on Midleg-Like Protein 4 (Isoform A)

Sex comb on midleg-like protein 4 (ISOform A) is a protein that is expressed in human plasm cells and is involved in the regulation of sexual behavior. It is a 21-kDa protein that consists of two distinct isoforms, ISOform A and ISOform B. ISOform A is the major isoform, while ISOform B is a less abundant isoform.

The protein encoded by SCML4 is composed of a unique domain that is found in a region between the N-terminus and the C-terminus of the protein. This domain is known as the \"sex comb\" domain and is responsible for the protein's unique structure and function.

The sex comb domain is a unique region that is composed of a series of amino acids that are involved in the formation of a comb-like structure on the protein. This comb-like structure is thought to play a role in the regulation of sexual behavior by interfering with the activity of other proteins that are involved in sexual behavior.

Despite the significant advances in our understanding of the biology of SCML4, there is still much that is not known about this protein. One of the main goals of research into SCML4 is to understand its role in sexual behavior and to identify potential drug targets or biomarkers that may be associated with this protein.

The Protein Structure and Functions

The sex comb domain is a unique region that is composed of a series of amino acids that are involved in the formation of a comb-like structure on the protein. This comb-like structure is thought to play a role in the regulation of sexual behavior by interfering with the activity of other proteins that are involved in sexual behavior.

The sex comb domain is located at the N-terminus of the protein and consists of the following amino acids:

* Asp at position -34
* Asn at position -33
* Asp at position -32
* Asn at position -31
* Asp at position -29
* Asn at position -28
* Asp at position -27
* Asn at position -26
* Asp at position -24
* Asn at position -23
* Asp at position -22
* Asn at position -21
* Asp at position -20
* Asn at position -19
* Asp at position -18
* Asn at position -17
* Asp at position -16
* Asn at position -15
* Asp at position -14
* Asn at position -13
* Asp at position -12
* Asn at position -11
* Asp at position -10
* Asn at position -9
* Asp at position -8
* Asn at position -7
* Asp at position -6
* Asn at position -5
* Asp at position -4
* Asn at position -3
* Asp at position -2
* Asn at position -1

The function of the sex comb domain is not well understood, but it is thought to play a role in the regulation of sexual behavior by interacting with the activity of other proteins.

Drug Targets and Biomarkers

Identification of drug targets and biomarkers for SCML4 is an important goal of research into this protein. Given its role in the regulation of sexual behavior, it is likely that SCML4 will be targeted by drugs that are designed to interfere with its activity.

One potential drug target for SCML4 is the inhibitor of nuclear export (SNX), which is a protein that is involved in the regulation of nuclear import and export. Given its role in the regulation of sexual behavior, it is

Protein Name: Scm Polycomb Group Protein Like 4

Functions: Putative Polycomb group (PcG) protein. PcG proteins act by forming multiprotein complexes, which are required to maintain the transcriptionally repressive state of homeotic genes throughout development (By similarity)

The "SCML4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SCML4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets